Comments about Dr. Chatfield from the 2020 Award recipients
Announcing the 2020 Barbara Chatfield Award Recipients!
Hayley was inspired to pursue higher education by the people around her. Watching them do the things they love inspired Hayley to find the career that makes everyday worth living for. Her ultimate goal is to fill her days with something she love to do. Growing up being told she might not make it as long as everybody else, Hayley decided to race towards the things she loves and to treasure them.
Erik feels that there's no limit to what he can learn and accomplish intellectually. Because of this, Erik was motivated to seek further education. He always enjoyed learning and discovering how to apply knowledge to real-world applications. Erik feels like he still has a ton of potential left untapped, and a higher education would be the way to maximize it. For a career, Erik is interested in two options. He would like to focus on Aerospace Engineering since he is absolutely fascinated with the cosmos and would love to be able to apply his intrinsic math ability to innovations in space. A second option is computer science because he loves the way computer logic works. Artificial intelligence seems absolutely groundbreaking, and Erik would also want to be at the forefront of this technological field. Ideally, he is going to try and combine these two fields or he hopes that college will give him new insights to help narrow down which of these he’d like to do.
Matthew aspires to be an aerospace engineer. He aims to do some of his lower level classes at BYU-Idaho then transfer to Utah State University as they are the only school in the area that currently has contracts with NASA, Boeing, and SpaceX for undergraduates. Matthew would like to be at SpaceX, Rocket Lab, or Blue Origin working on the rockets for space travel, or possibly helping with efforts for further exploration of Mars. He is fascinated with flight and physical mechanics.
The magical trident targeting CF
The FDA approved Trikafta on October 21, 2019, calling it a “new breakthrough therapy for cystic fibrosis”. Wow — I’ll always remember the time when Barb burst into tears as she read about the approval of Orkambi on her iPhone while we were on a plane to Hawaii in July 2015. So as I said in my speech at the Taste of Utah this year: “If she were still alive Barb would literally have cried tears of joy to hear about the FDA approval of Trikafta.”
Dr. Francis Collins, who played in critical role in identifying the CFTR gene, contributed an editorial to the New England Journal of Medicine detailing the journey leading up to the development of Trikafta. It is a great read. Some excerpts that hit home for me:
The diary entry of an 8-year-old girl with cystic fibrosis indicates that Aug. 25, 1989, was an important day for her. That was the day the research teams at the University of Michigan and the Hospital for Sick Children, Toronto, announced the discovery of the cystic fibrosis gene and the most common mutation, a three-base deletion that results in a missing phenylalanine in codon 508 (denoted the Phe508del CFTR mutation).
I was a first year faculty member at the University of Colorado and Barb was in the middle of her training to become a pediatric pulmonologist on the day of that announcement. We were giddy with excitement; gene therapy will cure this disease in 7…at most 10 years. Or so we thought - gene therapy for a cure continues to be maddeningly elusive. But until gene therapy is a reality, how about trying to nudge the abnormal CFTR protein to work like it’s supposed to work:
We hoped that the gene discovery would someday lead to effective treatments for children and adults with cystic fibrosis, but we knew that would be a long road. Now, 30 years later, that time has come. The results of a pair of phase 3 clinical trials in the Journal and in a simultaneous publication in the Lancet document impressive benefits from triple-drug therapy for persons with cystic fibrosis and at least one copy of the Phe508del CFTR mutation, who represent approximately 90% of persons affected by this life-shortening autosomal recessive disease.
Chillzzz…and cure by gene therapy is still a pressing goal:
This should be a cause for major celebration. Yet we must not abandon the patients with cystic fibrosis who have null mutations and will not have a response to these drugs. Even beyond that, the “best day ever” for all of us traveling down this long road together will be the day when the more than 70,000 persons with cystic fibrosis worldwide do not need to take drug therapy at all and there finally is a permanent cure for cystic fibrosis that works for everyone. Although the challenges are substantial, one can imagine such an ultimate approach involving in vivo somatic-cell gene editing of airway epithelial cells.
We’re fortunate that many very smart and dedicated people continue to work towards a cure for all those affected with CF. Dr. Collins closed the editorial with this heartfelt statement:
Shortly after our identification of CFTR, I wrote a song entitled “Dare to Dream.” The lyrics expressed hope that the gene discovery would lead to effective treatments for cystic fibrosis — that someday we would see “all our brothers and sisters breathing free.” It is profoundly gratifying to see that this dream is coming true.
Wait - Dr. Collins not only is the head of NIH, co-discoverer of the CF gene, led the Human Genome Project, received the Presidential Medal of Freedom and National Medal of Science…he’s also a Singer-Songwriter?! Yup - here’s the proof:
Postscript: Hopefully I won’t be thrown in jail for violation of the DRM music copyright law by posting this video. Just in case though, you may want to contribute to the “Get Derek Out of Jail Fund”
Congratulations Kathleen!
Kathleen was one of only two honorees chosen from a national field of highly qualified nominees to receive the prestigious Mary M. Kontos Care Champion Award at the 2019 North American Cystic Fibrosis Conference in Nashville TN. Here is what the CF Foundation says about the award and Kathleen on their website:
The Kontos Award, created in 2014, recognizes the contributions of nonphysician members of a care team who demonstrate a passion for excellence and commitment to care of individuals with cystic fibrosis.
Kathleen Richards
Respiratory therapist and pulmonary function lab supervisor at the Intermountain Cystic Fibrosis Center, University of Utah
For 25 years, Richards has long been involved in quality improvement. She participated in the first CF Foundation Learning and Leadership Collaborative in 2003-2004 and was a member of the CF pediatric benchmarking team in 2006. Richards helped develop the CF Foundation's Respiratory Therapy Mentoring Program, writing the Respiratory Therapy 101 document and serving as the facilitator for four years. In addition, she has served on the North American Cystic Fibrosis Conference (NACFC) Planning Committee since 2016. She also oversees the respiratory care for approximately 320 pediatric patients, including respiratory training for families of newly diagnosed children with CF.
“She puts my daughter's uncertainty and fears at ease the second she walks through the door at clinic. Managing CF is tough, and she empowers us and helps us navigate through our ever-changing emotions and struggles.” -- Parent of a pediatric patient with CF
Congratulations Kathleen! Barb would be so proud of her amazing friend and colleague!
Comments about Barb from the 2019 applicants
The recipients of the 2019 Barbara Chatfield Award for Academic Achievement will be announced at the Taste of Utah on October 26, 2019. Their names and a short biography are available on the previous blog post. Barb was the CF doctor for several of the recipients for many years. As evidenced by some of their memories shared below, Barb played a vital part in their lives. Dr. Chatfield would be so proud of their achievements!
We are pleased to announce the 2019 Barbara Chatfield Award Recipients!
Here are the 2019 recipients of the Barbara Chatfield Award for Academic Achievement. Dr. Chatfield would be so proud of each of them and their amazing accomplishments to further their education!
CONGRATULATIONS TO ALL OF THESE AMAZING STUDENTS!
Words About Dr. Chatfield
The recipients of the 2018 Barbara Chatfield Award for Academic Excellence will be announced at the Taste of Utah on November 3, 2018. Their names and a short biography also are available on the previous post on this blog. The awardees were carefully chosen based on their admirable achievements in pursuing their academic dreams. Applicants were also given an option to contribute their thoughts about Barb; these were not considered as part of the selection process. As evidenced by their touching words below, Barb played an important role in their lives. Dr. Chatfield would be so proud of their achievements!
We are pleased to announce the 2018 Award Recipients!
Emily graduated from Viewmont High School and is attending Utah State University. She loves to learn and be pushed at an accelerated pace. Emily feels that higher education is important to help you become a life long learner. Her ultimate career goal is to be a genetic counselor, which blends her love for psychology and medicine. She loves that this field provides for challenging research, a deep understanding of biology, and especially the important role of comforting patients.
Karlie graduated from Roy High School and is attending Weber State University. Her goal is to receive a Masters in Business Administration and minor in Dance and Fashion. With a business degree, she hopes to own a dance studio or enter into the world of fashion and grow as a person and entrepreneur. She feels that a degree in Business Administration will give her the skills to market herself, as well as teach her how to become a successful business owner and how to work well with large corporations.
George graduated from Coronado High School and is attending Utah Valley University. He has been inspired by his parents to further his education beyond high school. George feels that acquiring a higher education will be a crucial step in gaining independence and security as an adult. He hopes to establish a career in an area such as Architectural Design, which would give him an opportunity to think creatively while staying independent, stable, and secure.
Hayley graduated from Preston High School and is attending Brigham Young University Idaho. She was inspired to seek further education so that she could support herself and her family. Her ultimate goal for a career is one that would allow her to effectively manage work and family commitments.
Cassidy graduated from Orem High School and is attending Brigham Young University Provo. She has always set goals for herself to achieve and going to college has been a goal of hers for a long time. Cassidy’s passion for dancing has felt like a miracle to her, because CF has not stopped her from doing what she loves. She is currently a member of the BYU Cougarettes, the university’s nationally recognized Collegiate Dance team. Cassidy hopes to use her experiences and education to teach and inspire others.
Barb's speech at the 2015 Taste of Utah
At the 2015 Taste of Utah, the Utah Idaho Chapter of the CF Foundation showed a video in honor of Barb’s dedication to fight against cystic fibrosis, which can be viewed here. What follows is the speech that Barb gave after the video was shown. Her words are just as relevant today, as it was on November 21, 2015: